This inventor holds 5 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignee: Aprea Ab. Active years: 2005-2011.
Location History:
- Taby, SE (2005 - 2010)
- Täby, SE (2010 - 2011)
Company Filing History:
Years Active: 2005-2011
Title: Klas Wiman: Innovator in RNA Interference and Pharmaceutical Compounds
Introduction
Klas Wiman is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of compounds and methods for medical applications. With a total of 5 patents, Wiman's work focuses on innovative solutions for treating various diseases.
Latest Patents
Wiman's latest patents include groundbreaking research on compounds and methods for down-regulating the Wrap53 protein through RNA interference. This small nucleic acid molecule is designed to down-regulate the expression of the Wrap53 gene, utilizing RNAi technology. The patent details that at least one strand of this molecule is between 15 to 30 nucleotides in length, ensuring sufficient complementarity to the RNA of the Wrap53 gene for effective cleavage via RNA interference, making it a potential medicament.
Another significant patent involves azabicyclooctan-3-one derivatives, which outlines the compounds of Formula (1) and the processes for preparing them. This patent also discusses pharmaceutical compositions that include these compounds, highlighting their potential use in treating hyperproliferative diseases such as cancer, as well as autoimmune diseases and heart disease.
Career Highlights
Klas Wiman is currently associated with Aprea AB, where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to developing effective treatments that address critical health challenges.
Collaborations
Wiman collaborates with esteemed colleagues, including Vladimir Bykov and Galina Selivanova, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
Klas Wiman's contributions to biotechnology and pharmaceuticals demonstrate his dedication to advancing medical science. His innovative patents reflect a commitment to addressing significant health issues through cutting-edge research and development.